Partex
Eschborn
About Partex
Partex NV is the first digital pharma platform that is set to be the largest AI-powered Drug Assets Manager. With the power of AI at its core, we at Partex NV Group deliver faster, lower-cost healthcare innovations, validated by wet-lab and real-world evidence. Our pioneering digital platform enables smarter decision-making throughout the entire value chain. What sets us apart: - Within the Partex ecosystem, patients keep ownership of their data and they are rewarded for participating in research projects - Our AI/ML algorithms enable key industry players to develop life-saving drugs while also developing our own drug assets - A strong history of success and performance: from humble software beginnings to a fully-fledged platform with over 500 employees in 3 continents Our vision is to transform the Life science Industry by curing incurable diseases and increasing humanity's longevity. We dare to care! We have a global presence that extends from APAC to the Americas, with offices currently in India, Germany, Switzerland and USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Funding stage: Seed
- Last round: Seed (Jan 2024)
- Website: thepartex.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Blockchain, Health Care, Life Science
Canonical: https://fsome.com/organization/partex-195252 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.